pharmaphorum3 天
GSK’s Relvar Ellipta comes out on top in real world study
GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...
pharmaphorum6 年
FDA approves expanded use for GSK's COPD triple therapy
The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to ... s already approved combinations Relvar/Breo Ellipta and Anoro Ellipta.